Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Baxa Corp. — Predicate Candidate Screening

8 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

198 daysmedian FDA review time
324 days90th percentile
8clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K090917SURECONNECT CLOSED DRUG RECONSTITUTION AND TRANSFER SYSTEMBaxa Corp.2010-02-193240
K070163SWABBABLE CAP, MODEL 60205Baxa Corp.2007-08-031980
K062909REPEATER PUMP II TUBE SETSBaxa Corp.2007-03-091630
K022523RAPID-FILL TUBESET, MODEL 90005Baxa Corp.2002-08-12130
K002705EXACTA-MIX 2400 COMPOUNDING SYSTEM, MODEL EXACTA-MIX 2400Baxa Corp.2001-03-2821011
K983321MICROFUSE DUAL RATE INFUSERBaxa Corp.1998-10-06140
K951871PISTON SYRINGEBaxa Corp.1995-06-21610
K933506SYRINGE INFUSERBaxa Corp.1994-02-252200

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda